Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Kaplan

Showing results (1-10 of 226) with videos related to

Pageof 23
Sort By:
Digestive Diseases and Sciences|November 18, 2016
Prediction of Mortality in Chronic Liver Disease Using Non-hepatic Comorbidities: No SI of Relief as YetDavid E Kaplan
Cellular and Molecular Gastroenterology and Hepatology|February 18, 2017
Does Massive Antigen Burden Allow Hepatic Viruses to Induce Regulatory T Cells and Their Tolerance and Persistence?David E Kaplan
Gastroenterology & Hepatology|October 11, 2018
The Use of Statins in Patients With CirrhosisDavid E Kaplan
Digestive Diseases and Sciences|March 19, 2018
Cost/Benefit of Hepatitis C Treatment: It Does Not End with SVRDavid E Kaplan
U.S. News & World Report|March 27, 2007
A smokin' old time in TehranDavid E Kaplan
Gastroenterology Clinics of North America|November 25, 2015
Immunopathogenesis of Hepatitis C Virus InfectionDavid E Kaplan
Gastroenterology & Hepatology|August 23, 2019
Statins and Hepatocellular Carcinoma ProtectionDavid E Kaplan
U.S. News & World Report|April 24, 2007
How they do it better. More stressed, but still saferDavid E Kaplan
Annals of Internal Medicine|September 1, 2020
Hepatitis C VirusDavid E Kaplan
Digestive Diseases and Sciences|May 22, 2023
Statins in Cirrhosis: Trial Data Are in but the Jury Is Still OutDavid E Kaplan
Pageof 23

Showing results (1-10 of 226) with videos related to

Sort By:
Pageof 23
Digestive Diseases and Sciences|November 18, 2016
Prediction of Mortality in Chronic Liver Disease Using Non-hepatic Comorbidities: No SI of Relief as YetDavid E Kaplan
Cellular and Molecular Gastroenterology and Hepatology|February 18, 2017
Does Massive Antigen Burden Allow Hepatic Viruses to Induce Regulatory T Cells and Their Tolerance and Persistence?David E Kaplan
Gastroenterology & Hepatology|October 11, 2018
The Use of Statins in Patients With CirrhosisDavid E Kaplan
Digestive Diseases and Sciences|March 19, 2018
Cost/Benefit of Hepatitis C Treatment: It Does Not End with SVRDavid E Kaplan
U.S. News & World Report|March 27, 2007
A smokin' old time in TehranDavid E Kaplan
Gastroenterology Clinics of North America|November 25, 2015
Immunopathogenesis of Hepatitis C Virus InfectionDavid E Kaplan
Gastroenterology & Hepatology|August 23, 2019
Statins and Hepatocellular Carcinoma ProtectionDavid E Kaplan
U.S. News & World Report|April 24, 2007
How they do it better. More stressed, but still saferDavid E Kaplan
Annals of Internal Medicine|September 1, 2020
Hepatitis C VirusDavid E Kaplan
Digestive Diseases and Sciences|May 22, 2023
Statins in Cirrhosis: Trial Data Are in but the Jury Is Still OutDavid E Kaplan
Pageof 23